COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended	9 Months Ended
	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2023	Dec. 31, 2022	Nov. 07, 2023	Mar. 31, 2023
Loss Contingencies [Line Items]
Right of use lease asset	$ 951,466	$ 951,466	$ 951,466			$ 1,151,909
Letter of Credit	87,506	87,506	87,506
Operating lease expense			315,000	$ 411,000
Restricted Cash [Member]
Loss Contingencies [Line Items]
Letter of Credit	87,506	87,506	$ 87,506
Office And Laboratory Space [Member]
Loss Contingencies [Line Items]
Lease description			In December 2020, we entered into an agreement to lease approximately 2,823 square feet of office space and 1,807 square feet of laboratory space located at 11555 Sorrento Valley Road, Suite 203, San Diego, California 92121 and 11575 Sorrento Valley Road, Suite 200, San Diego, California 92121, respectively. The agreement carries a term of 63 months and we took possession of the office space effective October 1, 2021.
Lease frequency of periodic payment			monthly
Lease periodic payment			$ 13,772
Letter of Credit	46,726	46,726	$ 46,726
Manufacturing Space [Member]
Loss Contingencies [Line Items]
Lease description			In October 2021, we entered into another lease for approximately 2,655 square feet of space to house our manufacturing operations located at 11588 Sorrento Valley Road, San Diego, California 92121. The term is for 55 months and we took possession of the manufacturing space in August 2022.
Lease frequency of periodic payment			monthly
Lease periodic payment			$ 12,080
Letter of Credit	$ 40,780	$ 40,780	$ 40,780
Office Lab And Manufacturing Leases [Member]
Loss Contingencies [Line Items]
Remaining lease term	42 months	42 months	42 months
Lease weighted average discount rate	4.25%	4.25%	4.25%
Separation Agreement [Member] | Charles Fisher [Member]
Loss Contingencies [Line Items]
Aggregate severance payable	$ 460,000	$ 460,000	$ 460,000
Additional separation agreement terms	continued medical coverage under COBRA for a twelve month period that began on December 1, 2023 and the acceleration of 50% of his unvested options at the time of separation, and included a standard release of any and all potential claims against the Company.
Severance costs		891,844
Separation Agreement [Member] | Charles Fisher [Member] | Payroll And Related Expense [Member]
Loss Contingencies [Line Items]
Severance costs		479,624
Separation Agreement [Member] | Charles Fisher [Member] | Health Insurance And Other Benefits [Member]
Loss Contingencies [Line Items]
Severance costs		19,081
Separation Agreement [Member] | Charles Fisher [Member] | Stock Based Compensation [Member]
Loss Contingencies [Line Items]
Severance costs		$ 393,139
Executive Employment Agreement [Member] | Interim Chief Executive Officer [Member]
Loss Contingencies [Line Items]
Annual base salary					$ 500,000
Executive Employment Agreement [Member] | Senior Vice President And Chief Operating Officer [Member]
Loss Contingencies [Line Items]
Annual base salary					$ 390,000